MYRIAD GENETICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
MYRIAD GENETICS, INC. (MYGN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 11.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-07-31
- MYRIAD GENETICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 11.30M shares, a 36.14% increase year-over-year.
- MYRIAD GENETICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 9.60M shares, a 65.52% increase year-over-year.
- MYRIAD GENETICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.20M shares, a 38.98% increase year-over-year.
- MYRIAD GENETICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 8.30M shares, a 33.87% increase year-over-year.
- MYRIAD GENETICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 7.80M shares, a 30.00% increase from fiscal 2024.
- MYRIAD GENETICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 6.00M shares, a 17.65% increase from fiscal 2023.
- MYRIAD GENETICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.10M shares, a 15.91% increase from fiscal 2022.
- MYRIAD GENETICS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.40M shares, a 2.22% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 11.30M shares 10-Q · filed 2026-07-31 | 11.30M shares 10-Q · filed 2026-07-31 | ||||
| 2026-03-31 | 9.60M shares 10-Q · filed 2026-05-06 | |||||
| 2025-12-31 | 7.80M shares 10-K · filed 2026-02-24 | |||||
| 2025-09-30 | 8.20M shares 10-Q · filed 2025-11-04 | 8.20M shares 10-Q · filed 2025-11-04 | ||||
| 2025-06-30 | 8.30M shares 10-Q · filed 2026-07-31 | 8.30M shares 10-Q · filed 2026-07-31 | ||||
| 2025-03-31 | 5.80M shares 10-Q · filed 2026-05-06 | |||||
| 2024-12-31 | 6.00M shares 10-K · filed 2026-02-24 | |||||
| 2024-09-30 | 5.90M shares 10-Q · filed 2025-11-04 | 5.90M shares 10-Q · filed 2025-11-04 | ||||
| 2024-06-30 | 6.20M shares 10-Q · filed 2025-08-06 | 6.20M shares 10-Q · filed 2025-08-06 | ||||
| 2024-03-31 | 6.30M shares 10-Q · filed 2025-05-07 | |||||
| 2023-12-31 | 5.10M shares 10-K · filed 2026-02-24 | |||||
| 2023-09-30 | 5.30M shares 10-Q · filed 2024-11-08 | 5.30M shares 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | 5.50M shares 10-Q · filed 2024-08-07 | 5.50M shares 10-Q · filed 2024-08-07 | ||||
| 2023-03-31 | 5.60M shares 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | 4.40M shares 10-K · filed 2025-02-28 | |||||
| 2022-09-30 | 4.50M shares 10-Q · filed 2023-11-07 | 4.50M shares 10-Q · filed 2023-11-07 | ||||
| 2022-06-30 | 5.40M shares 10-Q · filed 2023-08-04 | 5.40M shares 10-Q · filed 2023-08-04 | ||||
| 2022-03-31 | 5.50M shares 10-Q · filed 2023-05-04 | |||||
| 2021-12-31 | 4.50M shares 10-K · filed 2024-02-28 | |||||
| 2021-09-30 | 100.00K shares 10-Q · filed 2022-11-02 | 4.90M shares 10-Q · filed 2022-11-02 | ||||
| 2021-06-30 | 7.00M shares 10-Q · filed 2022-08-05 | 7.00M shares 10-Q · filed 2022-08-05 | ||||
| 2021-03-31 | 300.00K shares 10-Q · filed 2022-05-06 | |||||
| 2020-12-31 | 6.60M shares 10-K · filed 2023-03-01 | |||||
| 2020-09-30 | 7.30M shares 10-Q · filed 2021-11-04 | 7.30M shares 10-Q · filed 2021-11-04 | ||||
| 2020-06-30 | 7.10M shares 10-Q · filed 2021-08-04 | 5.50M shares 10-K · filed 2023-03-01 | ||||
| 2020-03-31 | 400.00K shares 10-Q · filed 2021-05-05 | 900.00K shares 10-Q · filed 2020-05-06 | ||||
| 2019-12-31 | 900.00K shares 10-Q · filed 2020-02-07 | 1.30M shares 10-Q · filed 2020-02-07 | ||||
| 2019-09-30 | 1.70M shares 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | 800.00K shares 10-K · filed 2022-02-25 | |||||
| 2019-03-31 | 1.00M shares 10-Q · filed 2020-05-06 | 700.00K shares 10-Q · filed 2020-05-06 | ||||
| 2018-12-31 | 1.10M shares 10-Q · filed 2020-02-07 | 600.00K shares 10-Q · filed 2020-02-07 | ||||
| 2018-09-30 | 4.10M shares 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | 0.00 shares 10-KT · filed 2021-03-16 | |||||
| 2017-12-31 | 200.00K shares 10-Q · filed 2019-02-06 | 500.00K shares 10-Q · filed 2019-02-06 | ||||
| 2017-09-30 | 1.50M shares 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | 7.00M shares 10-K · filed 2019-08-13 | |||||
| 2017-03-31 | 9.20M shares 10-Q · filed 2018-05-09 | 7.00M shares 10-Q · filed 2018-05-09 | ||||
| 2016-12-31 | 8.70M shares 10-Q · filed 2018-02-07 | 6.40M shares 10-Q · filed 2018-02-07 | ||||
| 2016-09-30 | 9.60M shares 10-Q · filed 2017-11-08 | |||||
| 2016-06-30 | 0.00 shares 10-K · filed 2016-08-10 | |||||
| 2016-03-31 | 100.00K shares 10-Q · filed 2017-05-03 | |||||
| 2015-09-30 | 100.00K shares 10-Q · filed 2016-11-02 | |||||
| 2015-06-30 | 0.00 shares 10-K · filed 2016-08-10 | |||||
| 2015-03-31 | 100.00K shares 10-Q · filed 2016-05-04 | 52.00K shares 10-Q · filed 2015-05-06 | 41.00K shares 10-Q · filed 2015-05-06 | |||
| 2014-12-31 | 900.00K shares 10-Q · filed 2016-02-03 | 844.00K shares 10-Q · filed 2015-02-04 | 39.00K shares 10-Q · filed 2015-02-04 | |||
| 2014-09-30 | 200.00K shares 10-Q · filed 2015-11-04 | 184.00K shares 10-Q · filed 2014-11-05 | ||||
| 2014-06-30 | 0.00 shares 10-K · filed 2016-08-10 | 5.27M shares 10-K · filed 2014-08-13 | ||||
| 2014-03-31 | 5.30M shares 10-Q · filed 2015-05-06 | 6.98M shares 10-Q · filed 2015-05-06 | ||||
| 2013-12-31 | 8.50M shares 10-Q · filed 2015-02-04 | 7.14M shares 10-Q · filed 2015-02-04 | ||||
| 2013-09-30 | 5.35M shares 10-Q · filed 2014-11-05 | |||||
| 2013-06-30 | 5.14M shares 10-K · filed 2014-08-13 | |||||
| 2013-03-31 | 5.80M shares 10-Q · filed 2014-05-07 | 4.97M shares 10-Q · filed 2014-05-07 | ||||
| 2012-12-31 | 5.61M shares 10-Q · filed 2014-02-05 | 4.58M shares 10-Q · filed 2014-02-05 | ||||
| 2012-09-30 | 3.93M shares 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | 8.59M shares 10-K · filed 2014-08-13 | |||||
| 2012-03-31 | 7.59M shares 10-Q · filed 2013-05-08 | 8.64M shares 10-Q · filed 2013-05-08 | ||||
| 2011-12-31 | 9.70M shares 10-Q · filed 2013-02-06 | 8.77M shares 10-Q · filed 2013-02-06 | ||||
| 2011-09-30 | 8.49M shares 10-Q · filed 2012-11-09 | |||||
| 2011-06-30 | 8.67M shares 10-K · filed 2013-08-14 | |||||
| 2011-03-31 | 8.77M shares 10-Q · filed 2012-05-02 | 8.65M shares 10-Q · filed 2012-05-02 | ||||
| 2010-12-31 | 8.17M shares 10-Q · filed 2012-02-01 | 8.46M shares 10-Q · filed 2012-02-01 | ||||
| 2010-09-30 | 9.26M shares 10-Q · filed 2011-11-02 | |||||
| 2010-06-30 | 6.43M shares 10-K · filed 2012-08-15 | |||||
| 2009-06-30 | 3.09M shares 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |